0001372514-24-000093.txt : 20240703
0001372514-24-000093.hdr.sgml : 20240703
20240703151609
ACCESSION NUMBER: 0001372514-24-000093
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stengone Carmine N.
CENTRAL INDEX KEY: 0001861519
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 241099807
MAIL ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KIORA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001372514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 332 ENCINITAS BOULEVARD
STREET 2: SUITE 102
CITY: ENCINITAS
STATE: CA
ZIP: 92024
BUSINESS PHONE: 781-788-8869
MAIL ADDRESS:
STREET 1: 332 ENCINITAS BOULEVARD
STREET 2: SUITE 102
CITY: ENCINITAS
STATE: CA
ZIP: 92024
FORMER COMPANY:
FORMER CONFORMED NAME: EYEGATE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060811
4
1
wk-form4_1720034163.xml
FORM 4
X0508
4
2024-07-01
0
0001372514
KIORA PHARMACEUTICALS INC
KPRX
0001861519
Stengone Carmine N.
C/O KIORA PHARMACEUTICALS, INC.
332 ENCINITAS BLVD., SUITE 102
ENCINITAS
CA
92024
1
0
0
0
0
Stock Option (right to buy)
4.35
2024-07-01
4
A
0
1778
0
A
2025-07-01
2034-07-01
Common Stock
1778
1778
D
The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on July 1, 2025.
/s/ Melissa Tosca, Attorney-in-Fact
2024-07-03